...3D Medicines Corp. raised RMB1.5 billion ($224.8 million) in an undisclosed financing round led by CPE...

...Partners and was one of the architects of BMS’s $74 billion takeout of Celgene Corp. CPE...

...is used. Cells are added to the mixture and incubated, and scored for cytopathic effect (CPE...

...the addition of poly(A) tails in the 3’ UTRs of transcripts, dubbed cytoplasmic polyadenylation elements (CPE...

...and CFO Gregory Gould. Last September, a JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE...

...A newly formed JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE Funds, the private equity...
...entity under the name ProductsCo. 3SBio will own 51% of the JV and has granted CPE...

...A newly formed JV between biosimilars company 3SBio Inc. (HKSE:1530) and CPE Funds, the private equity...
...entity under the name ProductsCo. 3SBio will own 51% of the JV and has granted CPE...

...in annual dividends. Testim, which is marketed by Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL, Malvern, Pa.), uses CPE-125...

...CPE) as a metastasis biomarker In vitro mouse and patient sample studies suggest that truncated CPE...
...HCC) and head and neck cancer. Metastatic HCC cell lines had greater levels of truncated CPE...
...lines. In mice injected with highly metastatic HCC cells, small interfering RNA-mediated knockdown of truncated CPE...

...CPEX's assets. CPEX's Nasulin intranasal insulin is in Phase II testing for diabetes and its CPE-215...